Cardiac Disease Status Dictates Functional mRNA Targeting Profiles of Individual MicroRNAs

Scot J Matkovich1, Gerald W Dorn2, Tiffani C Grossenheider2

  • 1From the Department of Internal Medicine, Center for Pharmacogenomics, Washington University School of Medicine, St. Louis, MO. smatkovi@dom.wustl.edu.

Abstract

Insights

Cardiac microRNA targeting shifts significantly during pressure overload. Understanding these changes is crucial for defining microRNA roles in heart disease and developing targeted therapies.

Area of Science:

  • Cardiovascular Biology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are critical regulators of cardiac stress responses.
  • The specific messenger RNAs (mRNAs) affected by cardiac miRNAs under stress are not fully understood.
  • Cardiac transcriptome-wide changes suggest miRNA targeting may differ between healthy and stressed states.

Purpose of the Study:

  • To investigate how microRNA target profiles change in mouse hearts during pressure overload hypertrophy.
  • To test the hypothesis that miRNA targeting differs between unstressed and stressed cardiac conditions.

Main Methods:

  • Utilized Ago2 immunoprecipitation followed by RNA sequencing (RISC-seq) to unbiasedly identify miRNA-dependent and -independent mRNA alterations.
  • Analyzed approximately 13,000 mRNAs in response to transverse aortic constriction (TAC).

Main Results:

  • During TAC, only 11% of miR-133a direct targets and 9% of miR-378 direct targets remained significantly regulated.
  • Widespread alterations in signaling function were observed due to changes in miRNA direct target selection during TAC.
  • Identified novel miRNA-mediated regulatory events specific to pressure overload conditions.

Conclusions:

  • Pressure overload significantly alters microRNA targeting profiles in the cardiac tissue.
  • The findings underscore the necessity of defining miRNA targets within specific tissue, cell, and physiological contexts for accurate understanding of cardiac function and dysfunction.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
MicroRNAs01:22

MicroRNAs

12.0K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
77